Analyst Pete Stavropoulos works at CANTOR FITZGERALD and is focused on the Healthcare sector with 16 price targets and ratings documented since 2021 spanning on 3 stocks. Analyst's average stock valuation to be materialised ratio is 11.11% with an average time for price targets to be met of 66.33 days.
Most recent stock forecast was given on PLRX, at 23-Jan-2023.
Pete Stavropoulos best performing recommendations are on PLRX.
The best stock recommendation documented was for PLRX at 7/11/2022. The price target of $36 was fulfilled within 199 days with a profit of $13 (56.52%) receiving and performance score of 2.84.
Average potential price target upside
Current price target
Previous price target
Price targets met ratio
Average potential upside
Average time for PT to be met
1 years 1 months 1 days ago
2 years 11 days ago